NO157979C - Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive benzotiazindioksyd-salter. - Google Patents

Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive benzotiazindioksyd-salter.

Info

Publication number
NO157979C
NO157979C NO821767A NO821767A NO157979C NO 157979 C NO157979 C NO 157979C NO 821767 A NO821767 A NO 821767A NO 821767 A NO821767 A NO 821767A NO 157979 C NO157979 C NO 157979C
Authority
NO
Norway
Prior art keywords
benzotiazine
preparation
therapeutically active
new therapeutically
analogue procedure
Prior art date
Application number
NO821767A
Other languages
English (en)
Norwegian (no)
Other versions
NO157979B (no
NO821767L (no
Inventor
Joseph George Lombardino
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO821767L publication Critical patent/NO821767L/no
Publication of NO157979B publication Critical patent/NO157979B/no
Publication of NO157979C publication Critical patent/NO157979C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO821767A 1981-06-01 1982-05-27 Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive benzotiazindioksyd-salter. NO157979C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26898081A 1981-06-01 1981-06-01
US06/367,067 US4434164A (en) 1981-06-01 1982-04-13 Crystalline benzothiazine dioxide salts

Publications (3)

Publication Number Publication Date
NO821767L NO821767L (no) 1982-12-02
NO157979B NO157979B (no) 1988-03-14
NO157979C true NO157979C (no) 1988-06-22

Family

ID=26953436

Family Applications (1)

Application Number Title Priority Date Filing Date
NO821767A NO157979C (no) 1981-06-01 1982-05-27 Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive benzotiazindioksyd-salter.

Country Status (27)

Country Link
US (1) US4434164A (da)
EP (1) EP0066459B1 (da)
KR (1) KR850001883B1 (da)
AU (1) AU529386B2 (da)
BG (1) BG37377A3 (da)
CA (1) CA1209571A (da)
DD (1) DD211560A5 (da)
DE (1) DE3260718D1 (da)
DK (1) DK149024C (da)
EG (1) EG15811A (da)
ES (1) ES512723A0 (da)
FI (1) FI74705C (da)
GB (1) GB2101589A (da)
GR (1) GR75476B (da)
HK (1) HK65386A (da)
HU (1) HU189586B (da)
IE (1) IE53160B1 (da)
IL (1) IL65917A (da)
MX (1) MX6984E (da)
MY (1) MY8700126A (da)
NO (1) NO157979C (da)
NZ (1) NZ200801A (da)
OA (1) OA07114A (da)
PH (1) PH17906A (da)
PT (1) PT74977B (da)
RO (1) RO84698B (da)
YU (1) YU42767B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5913714A (ja) * 1982-07-13 1984-01-24 Taito Pfizer Kk 外用消炎鎮痛剤
RO88420A (ro) * 1983-04-25 1986-01-30 Pfizer Inc,Us Procedeu pentru prepararea unor saruri bazice de piroxican depuse pe suporturi farmaceutice
DE3431588A1 (de) * 1983-09-12 1985-04-04 Pfizer, Inc., New York, N.Y. Kristalline benzothiazindioxid-salze und diese enthaltende pharmazeutische zusammensetzungen
DE3346526C2 (de) * 1983-12-22 1986-12-11 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutisches Präparat zur therapeutischen Behandlung von rheumatischen Erkrankungen
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US4582831A (en) 1984-11-16 1986-04-15 Pfizer Inc. Anti-inflammatory polymorphic monoethanolamine salt of N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide compound, composition, and method of use therefor
US4559326A (en) * 1985-01-31 1985-12-17 Pfizer Inc. Antiinflammatory compositions and methods
US4623486A (en) * 1985-05-29 1986-11-18 Pfizer Inc. [4-substituted benzoyloxy]-N-substituted-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides having anti-arthritic activity
US4610982A (en) * 1985-06-03 1986-09-09 Pfizer Inc. Anti-inflammatory benzo- and thieno-1,2-thiazine-3-carboxamide 1,1-dioxide derivatives, compositions, and method of use therefor
KR890001236B1 (ko) * 1985-10-02 1989-04-28 화이자 인코포레이티드 소염제 조성물의 제조방법
HU200926B (en) * 1988-10-28 1990-09-28 Egyt Gyogyszervegyeszeti Gyar Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules
IT1247492B (it) * 1991-04-18 1994-12-17 Francia Farma Sali ad attivita' antiinfiammatoria, antisettica, detergente e composizioni farmaceutiche
IT1283252B1 (it) * 1996-03-15 1998-04-16 Pulitzer Italiana Soluzioni di piroxicam iniettabili per via parenterale
GB0031107D0 (en) * 2000-12-20 2001-01-31 Glaxo Group Ltd Chemical compounds
FR2818641B1 (fr) * 2000-12-21 2004-03-05 Servier Lab Nouveaux derives de 1,1-dioxo-2h-1,2-benzothiazine 3-carboxamides, leur procede de preparation et les compositions pharmaceutiques que les contiennent
KR100446829B1 (ko) * 2002-02-20 2004-09-04 한국유나이티드제약 주식회사 가용화된 피록시캄을 함유한 확산형 정제의 조성물 및그의 제조방법
EP2792353B1 (en) 2003-05-22 2018-02-28 United Therapeutics Corporation Polymorph of Treprostinil diethanolamine salt
US20050176809A1 (en) * 2004-02-05 2005-08-11 Rodlen Laboratories, Inc. Method and compositions for treatment of painful disorders
EP1893190A4 (en) * 2005-04-28 2010-07-28 Theraquest Biosciences Llc METHODS AND COMPOSITIONS FOR TREATING PAIN
US8747897B2 (en) 2006-04-27 2014-06-10 Supernus Pharmaceuticals, Inc. Osmotic drug delivery system
EP2252570B1 (en) 2007-12-17 2017-04-05 United Therapeutics Corporation An improved process to prepare treprostinil, the active ingredient in remodulin ®
EP3209415B1 (en) 2014-10-20 2020-02-19 United Therapeutics Corporation Synthesis of intermediates for producing prostacyclin derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591584A (en) 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US4074048A (en) 1976-05-10 1978-02-14 Warner-Lambert Company Process for the preparation of 4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides
US4100347A (en) 1976-06-10 1978-07-11 Pfizer Inc. 3,4-Dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide
DE2756113A1 (de) 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4289879A (en) 1980-09-29 1981-09-15 Pfizer Inc. Synthetic method and intermediate for piroxicam

Also Published As

Publication number Publication date
MX6984E (es) 1987-01-19
NO157979B (no) 1988-03-14
IL65917A (en) 1985-08-30
DD211560A5 (de) 1984-07-18
EP0066459B1 (en) 1984-09-12
GB2101589A (en) 1983-01-19
IE53160B1 (en) 1988-08-03
KR850001883B1 (ko) 1985-12-28
NO821767L (no) 1982-12-02
HU189586B (en) 1986-07-28
DE3260718D1 (de) 1984-10-18
AU529386B2 (en) 1983-06-02
NZ200801A (en) 1985-01-31
EP0066459A1 (en) 1982-12-08
ES8307775A1 (es) 1983-08-01
MY8700126A (en) 1987-12-31
FI74705C (fi) 1988-03-10
HK65386A (en) 1986-09-12
YU113782A (en) 1984-12-31
EG15811A (en) 1986-12-30
RO84698B (ro) 1984-09-30
FI821918A0 (fi) 1982-05-31
PH17906A (en) 1985-01-25
DK149024C (da) 1986-06-30
AU8432282A (en) 1982-12-09
IL65917A0 (en) 1982-08-31
CA1209571A (en) 1986-08-12
YU42767B (en) 1988-12-31
BG37377A3 (en) 1985-05-15
ES512723A0 (es) 1983-08-01
DK149024B (da) 1985-12-23
OA07114A (fr) 1984-03-31
RO84698A (ro) 1984-07-17
DK241682A (da) 1982-12-02
US4434164A (en) 1984-02-28
GR75476B (da) 1984-07-23
IE821286L (en) 1982-12-01
KR830010108A (ko) 1983-12-26
PT74977B (en) 1985-05-17
PT74977A (en) 1982-06-01
FI74705B (fi) 1987-11-30

Similar Documents

Publication Publication Date Title
NO157979C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive benzotiazindioksyd-salter.
NO154521C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive piperidinderivater.
NO163691C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-acryl-piperazinalkanamider.
NO156785C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO871879D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktive heterocykliske forbindelser.
NO810765L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater.
NO159016C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminderivater.
NO870240L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno-1,4-diazepiner.
NO891191D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk virksomme catecholderivater.
NO160444C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive imidazo-pyrazolo-pyrimidiner.
NO166281C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,1-disubstituerte cyklopropanderivater.
NO823520L (no) Fremgangsmaate ved fremstilling av nye, terapeutisk aktive carbohydrater.
NO159930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater.
NO154268C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 6alfa-flour-9a-klor-prednisolon-17,21-diestere.
NO870998L (no) FremgangsmŸte for fremstilling av nye, terapeutisk aktive acetamid-derivater.
NO165916C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, ikke-aromatiske fluorallylamin mao-inhibitorer.
NO165679C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskvirksomme androstan-17beta-karboksyl-syreestere.
NO159090C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
NO152698C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzosyrederivater.
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.
NO158800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater.
NO822119L (no) Fremgangsmaate for fremstilling av farmakologisk aktive benztriazol-derivater.
NO158063C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo-pyrido-diazepin-derivater.
NO865148D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte benzamider.
NO891025D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktive sialosylglycerider.

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN MAY 2002